United Therapeutics Stock Target Price and Analyst Consensus

UTHR Stock  USD 293.62  0.00  0.00%   
The current analyst and expert consensus on United Therapeutics is Buy with 6 hold recommendations. The current projected United Therapeutics target price consensus is 388.18 with 14 analyst opinions. One of the most common ways United Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to United Therapeutics vendors, executives, and/or customers. United Therapeutics recommendation module provides expert sentiment on the projected United Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 2.3529.
Lowest Forecast
353.25
Highest Forecast
430.88
Target Price
388.18
At this time, United Therapeutics' Gross Profit is relatively stable compared to the past year. As of 07/21/2025, Pretax Profit Margin is likely to grow to 0.56, while Gross Profit Margin is likely to drop 0.58. At this time, United Therapeutics' Cash is relatively stable compared to the past year. As of 07/21/2025, Non Current Assets Total is likely to grow to about 3.7 B, though Net Debt is likely to grow to (1.3 B).
It's important to approach United Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize United Therapeutics price targets

United Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using United Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at United Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if United Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional United Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of United Therapeutics is a key component of United Therapeutics valuation and have some predictive power on the future returns of a United Therapeutics.
Hype
Prediction
LowEstimatedHigh
291.25293.62295.99
Details
Intrinsic
Valuation
LowRealHigh
264.26314.48316.85
Details
Naive
Forecast
LowNextHigh
284.82287.19289.56
Details
Earnings
Estimates (0)
LowProjected EPSHigh
5.927.358.08
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as United Therapeutics. Your research has to be compared to or analyzed against United Therapeutics' peers to derive any actionable benefits. When done correctly, United Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in United Therapeutics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
FinTech Idea
FinTech
Invested over 30 shares
Momentum Idea
Momentum
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Chemicals Idea
Chemicals
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Cash Cows Idea
Cash Cows
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares

Additional Tools for United Stock Analysis

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.